机译:[ZR-89] ZR-DFO-MSTP2109A抗-SEAP1抗体在转移性阉割的前列腺癌患者中的药代动力学和生物分布
Mem Sloan Kettering Canc Ctr Dept Med Phys New York NY 10065 USA;
Mem Sloan Kettering Canc Ctr Dept Med New York NY 10065 USA;
Mem Sloan Kettering Canc Ctr Dept Radiol New York NY 10065 USA;
Mem Sloan Kettering Canc Ctr Dept Radiol New York NY 10065 USA;
Mem Sloan Kettering Canc Ctr Dept Radiol New York NY 10065 USA;
Mem Sloan Kettering Canc Ctr Dept Radiol New York NY 10065 USA;
Mem Sloan Kettering Canc Ctr Dept Radiol New York NY 10065 USA;
Mem Sloan Kettering Canc Ctr Dept Radiol New York NY 10065 USA;
Mem Sloan Kettering Canc Ctr Dept Med Phys New York NY 10065 USA;
Mem Sloan Kettering Canc Ctr Dept Med New York NY 10065 USA;
Mem Sloan Kettering Canc Ctr Radiochem Core Facil New York NY 10065 USA;
Genentech Inc San Francisco CA 94080 USA;
Mem Sloan Kettering Canc Ctr Dept Med New York NY 10065 USA;
Genentech Inc San Francisco CA 94080 USA;
Mem Sloan Kettering Canc Ctr Dept Med Phys New York NY 10065 USA;
Mem Sloan Kettering Canc Ctr Dept Radiol New York NY 10065 USA;
Mem Sloan Kettering Canc Ctr Dept Med New York NY 10065 USA;
Mem Sloan Kettering Canc Ctr Dept Radiol New York NY 10065 USA;
STEAP1; Zr-89; antibody; positron; prostate cancer;
机译:[ZR-89] ZR-DFO-MSTP2109A抗-SEAP1抗体在转移性阉割的前列腺癌患者中的药代动力学和生物分布
机译:逐步增加剂量的223 Ra-二氯化物在去势抵抗性转移性前列腺癌男性中的一期药代动力学和生物分布研究
机译:99mTc标记的前列腺特异性膜抗原小分子抑制剂:在健康受试者和转移性前列腺癌患者中的药代动力学和生物分布研究
机译:转移激素敏感和阉割的前列腺癌:进步和持续发现的十年
机译:改善肌横截面积,并且在具有转移阉割的前列腺癌接受雄激素剥夺治疗的男性中的男性锻炼之后,将物理静脉凝集维持
机译:使用89Zr-DFO-MSTP2109A Anti-STEAP1抗体对转移性去势抵抗性前列腺癌患者进行成像
机译:使用89ZR-DFO-MSTP2109A抗STEAP1抗体的成像患者抗转移性阉割前列腺癌